Bergan Kdv Wealth Management, LLC Charles River Laboratories International, Inc. Transaction History

Bergan Kdv Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	SELL	$182.44 - $250.54 $1,641 - $2,254	-9 Reduced 60.0%	6 $1,000
Q4 2020 Feb 04, 2021	BUY	$222.0 - $252.62 $1,110 - $1,263	5 Added 50.0%	15 $4,000
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $1,426 - $2,276	-12 Reduced 54.55%	10 $2,000
Q1 2020 Apr 24, 2020	BUY	$98.9 - $178.34 $395 - $713	4 Added 22.22%	22 $3,000
Q4 2019 Feb 10, 2020	BUY	$126.05 - $152.76 $2,268 - $2,749	18 New	18 $3,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.